ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

ClinicalTrials.gov ID: NCT06568042

Public ClinicalTrials.gov record NCT06568042. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 10:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Finding Study Evaluating LY3848575 in Chronic Neuropathic Pain Associated With Distal Sensory Polyneuropathy

Study identification

NCT ID
NCT06568042
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
558 participants

Conditions and interventions

Interventions

  • LY3848575 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 21, 2024
Primary completion
May 31, 2026
Completion
Aug 31, 2026
Last update posted
Apr 26, 2026

2024 – 2026

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
MD First Research - Chandler Chandler Arizona 85286
HOPE Research Institute Phoenix Arizona 85032
Neuro-Pain Medical Center Fresno California 93710
Alpine Clinical Research Center Boulder Colorado 80301
Accel Research Sites - St. Pete-Largo Clinical Research Unit Largo Florida 33777
Design Neuroscience Center Miami Lakes Florida 33016
Conquest Research - Orlando Orlando Florida 32832
Charter Research - Lady Lake The Villages Florida 32162
Encore Medical Research - Weston Weston Florida 33331
Conquest Research Winter Park Florida 32789
Integrated Clinical Trial Services, Inc. West Des Moines Iowa 50265
Lucida Clinical Trials New Bedford Massachusetts 02740
SKY Integrative Medical Center/SKYCRNG Ridgeland Mississippi 39157
StudyMetrix Research City of Saint Peters Missouri 63303
Mid Hudson Medical Research New Windsor New York 12553
University of Rochester Medical Center Rochester New York 14618
Asheville Neurology Specialists, PA Asheville North Carolina 28806
Center for Clinical Research Winston-Salem North Carolina 27103
Neurology Diagnostics, Inc. Dayton Ohio 45459
New Phase Research and Development Knoxville Tennessee 37909
Cedar Health Research Dallas Texas 75251
Biopharma Informatic, LLC Houston Texas 77043
Clinical Trial Network Houston Texas 77074
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06568042, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06568042 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →